ICD Code E11.3513
ICD code E11.3513 is for type 2 diabetes with proliferative diabetic retinopathy and macular edema affecting both eyes.
Boost patient experience and your bottom line by automating patient cost estimates, payer underpayment detection, and contract optimization in one place.
What is ICD diagnosis code E11.3513
ICD code E11.3513 is type 2 diabetes mellitus with proliferative diabetic retinopathy and macular edema in both eyes.
When to use ICD code E11.3513
1. Patient has a confirmed diagnosis of type 2 diabetes mellitus.
2. Evidence of proliferative diabetic retinopathy is present on ophthalmologic examination.
3. Macular edema is documented in both eyes (bilateral involvement).
4. No indication of type 1 diabetes or other specific diabetes types.
5. Clinical documentation supports the coexistence of all the above conditions at the time of encounter.
Billable CPT codes for ICD code E11.3513
Applicable CPT codes for ICD code E11.3513 may include:
- 67028 (Intravitreal injection of a pharmacologic agent)
- 67210 (Destruction of localized lesion of retina, photocoagulation)
- 67228 (Treatment of extensive or progressive retinopathy, photocoagulation)
- 92134 (Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina)
- 92235 (Fluorescein angiography with interpretation and report, unilateral or bilateral)
- 92240 (Indocyanine-green angiography with interpretation and report, unilateral or bilateral)
- 92083 (Visual field examination, extended)
Selection of CPT codes should be based on the specific services rendered.
Are you being underpaid for encounters with E11.3513
Schedule a demo to see how MD Clarity’s RevFind software can automatically read your contracts and detect underpayments for CPT codes related to ICD code E11.3513. Discover how easy it is to ensure you’re being paid accurately for the care you provide.
Get paid in full by bringing clarity to your revenue cycle
Related ICD Codes
Subscribe to the

Healthcare Clarified newsletter
Get the latest insights on RCM and healthcare policy in your inbox
